In vitro activity of newer β-lactam agents in combination with amikacin against Pseudomonas aeruginosa, Klebsiella pneumoniae, and Serratia marcescens

https://doi.org/10.1016/0732-8893(83)90004-4Get rights and content

Abstract

The in vitro activity of cefoperazone, ceftazidime, ceftizoxime, moxalactam, and N-forminidoyl thienamycin was evaluated alone and in combination with amikacin to assess possible synergistic activity against isolates of amikacin-resistant Pseudomonas aeruginosa and multidrug-resistant Serratia marcescens and Klebsiella pneumoniae susceptible to amikacin (one S. marcescens isolate was also resistant to amikacin). The checkerboard agar dilution method was used. Ceftazidime and thienamycin followed by moxalactam and cefoperazone were the most active agents versus the P. aeruginosa alone and in combination testing. Ceftazidime, moxalactam, and thienamycin showed the greatest activity against S. marcescens, and all agents except cefoperazone were active against K. pneumoniae. The finding of synergy or partial synergy in combination testing was found in the majority with all three genera, including levels below the breakpoint for both amikacin and the β-lactam agents. This wide in vitro activity indicates that clinical evaluation of these agents in treatment of multidrug-resistant infections is warranted.

References (22)

  • RD Meyer et al.

    Gentamicin-resistant Pseudomonas aeruginosa and Serratia marcescens in a general hospital

    Lancet

    (1976)
  • AW Bauer et al.

    Antibiotic susceptibility testing by a standardized single disk method

    Am J Pathol

    (1966)
  • HM Ericsson et al.

    Antibiotic sensitivity testing: Report of an international collaborative study

    Acta Pathol Microbiol Scand Sect B

    (1971)
  • RJ Fass

    Comparative in vitro activities of β -lactam-tobramycin combinations against Pseudomonas aeruginosa and multidrug-resistant gram-negative enteric bacilli

    Antimicrob Agents Chemother

    (1982)
  • KP Fu et al.

    In vitro synergistic effect of netilmicin, a new aminoglycoside antibiotic

    Antimicrob Agents Chemother

    (1976)
  • DN Gilbert et al.

    Effect of the concentrations of magnesium and calcium on the in vitro susceptibility of Pseudomonas aeruginosa to gentamicin

    J Infect Dis

    (1971)
  • AM Hinkle et al.

    In vitro evaluation of cefoperazone

    Antimicrob Agents Chemother

    (1980)
  • RN Jones et al.

    Moxalactam (LY127935), a new semisynthetic l-oxa-β-lactam antibiotic with remarkable antimicrobial activity: In vitro comparison with cefamandole and tobramycin

    Antimicrob Agents Chemother

    (1980)
  • RN Jones et al.

    Antimicrobial activity of amikacin combinations against Entero-bacteriaceae moderately susceptible to third-generation cephalosporins

    Antimicrob Agents Chemother

    (1982)
  • T Kamimura et al.

    Ceftizoxime (FK 749), a new parenteral cephalosporin: In vitro and in vivo antibacterial activities

    Antimicrob Agents Chemother

    (1979)
  • TO Kurtz et al.

    Comparative in vitro synergistic activity of new beta-lactam antimicrobial agents and amikacin against Pseudomonas aeruginosa and Serratia marcescens

    Antimicrob Agents Chemother

    (1981)
  • Cited by (0)

    View full text